Skip to main content
Compugen Ltd. logo

Compugen Ltd. — Investor Relations & Filings

Ticker · CGEN ISIN · IL0010852080 TA Professional, scientific and technical activities
Open in API
Filings indexed 1,159 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country IL Israel
Listing TA CGEN

About Compugen Ltd.

https://www.cgen.com/

Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in cancer immunotherapy. A pioneer in its field, the company leverages a proprietary, broadly applicable, and predictive AI-powered computational discovery platform to identify novel drug targets. Its primary focus is on developing innovative, first-in-class therapeutics designed to modulate the tumor microenvironment and enhance anti-tumor immune responses. Compugen's mission is to advance its pipeline of drug candidates to address patient populations unresponsive to current immunotherapy treatments.

Recent filings

Filing Released Lang Actions
Compugen to Release First Quarter 2026 Results on May 18, 2026 will host a conference call at 8:30 AM ET
Regulatory Filings
2026-05-04 English
Compugen to Release First Quarter 2026 Results on May 18, 2026 will host a conference call at 8:30 AM ET
Regulatory Filings
2026-05-04 English
Other Report or Announcement
Director's Dealing Classification · 1% confidence The document is a U.S. SEC Form 4 (“Statement of Changes in Beneficial Ownership”) filed under Section 16 of the Securities Exchange Act, reporting insider transactions by a company officer/director. This matches the definition for Director’s Dealing (insider share transactions).
2026-04-28 English
Other Report or Announcement
Director's Dealing Classification · 1% confidence The document is an immediate report filed under Israeli Securities Regulations, indicating “Attached hereto is a report on Form 4 – Zurit Levine.” Form 4 corresponds to insider share transactions by directors or executives. Therefore this is a Director’s Dealing filing (insider trade report).
2026-04-28 English
Other Report or Announcement
Director's Dealing Classification · 1% confidence The document is an SEC Form 4 reporting an insider’s (a director/officer’s) acquisition and disposition of company shares pursuant to Rule 10b5-1 trading plan. This is a classic insider trading (director dealing) report, matching the “Director's Dealing” category.
2026-04-28 English
Other Report or Announcement
Director's Dealing Classification · 1% confidence The document is an immediate report under Regulation 5 of the Israeli Securities Regulations and attaches a Form 4 for Eran Ophir, which is a filing of personal share transactions by a company officer (insider dealing). This corresponds to Director's Dealing.
2026-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.